Evolus (EOLS) Beginning Cash Balance (2017 - 2018)

Evolus (EOLS) reported Beginning Cash Balance of $5.0 million for Q1 2018, up 100.0% quarter-over-quarter from $2.5 million in Q4 2017.

Evolus (EOLS) Beginning Cash Balance (2017 - 2018) Analysis & Trends

Evolus has reported Beginning Cash Balance for 2 years, with the latest figure at $5.0 million in Q1 2018.

For the quarter ending Q1 2018, Beginning Cash Balance changed N/A year-over-year to $5.0 million; the trailing twelve-month figure through Dec 2018 stood at $5.0 million (up 100.0% YoY), and the FY2018 full-year result was $5.0 million, changed N/A from the prior year.
Beginning Cash Balance for Q1 2018 stood at $5.0 million, up from $2.5 million in the prior quarter.
The five-year high for Beginning Cash Balance was $5.0 million in Q1 2018, with the low at $2.5 million in Q4 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn
10	Evolus	437.40 Mn	387.61 Mn	48.90 Mn

Download Data